Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Zogenix, Inc.    ZGNX

ZOGENIX, INC. (ZGNX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/16/2018 07/17/2018 07/18/2018 07/19/2018 07/20/2018 Date
60.95(c) 61.1(c) 59.2(c) 58.95(c) 58.4(c) Last
961 490 546 611 613 894 624 845 343 607 Volume
-0.65% +0.25% -3.11% -0.42% -0.93% Change
More quotes
Financials (USD)
Sales 2018 -
EBIT 2018 -131 M
Net income 2018 -130 M
Debt 2018 -
Yield 2018 -
Sales 2019 51,6 M
EBIT 2019 -69,5 M
Net income 2019 -68,5 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 0
Capi. / Sales2019 40,0x
Capitalization 2 062 M
More Financials
Company
Zogenix, Inc. is a pharmaceutical compan.It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders.Its products include ZX008 and Relday.The company was founded by Stephen J. Farr, Cam L.... 
More about the company
Surperformance© ratings of Zogenix, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOGENIX, INC.
07/17Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Health..
AC
07/16TODAY'S RESEARCH REPORTS ON TRENDING : Zogenix and Momenta Pharmaceuticals
AC
07/16ZOGENIX : Announces Positive Top-line Results from Second Pivotal Phase 3 Clinic..
AQ
07/13TODAY'S RESEARCH REPORTS ON STOCKS T : Galmed Pharmaceuticals and Zogenix
AC
07/13ZOGENIX : to submit anti-seizure drug for approval after clinical trial confirms..
AQ
07/12ZOGENIX : takes off on test results
AQ
07/12ZOGENIX, INC. : Other Events (form 8-K)
AQ
07/12Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clini..
GL
07/06ZOGENIX : Welcomes New Global Chief Commercial Officer
AQ
07/06ZOGENIX : Reports Granting of Inducement Awards under Nasdaq Listing Rule 5635(4..
AQ
More news
Sector news : Bio Medical Devices
07/19Novartis, MorphoSys and Galapagos Shares Rise on News of Deal
DJ
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
More sector news : Bio Medical Devices
Latest Tweets
07/20These Epilepsy Drugmakers Are About to Brawl: In patients with tough-to-treat.. 
07/14Brainstorm Health: Gym tax deduction, Zogenix stock, J&J verdict
3
07/14The mystery of what happened to Janet and Mark Davies remained unsolved for m.. 
07/13JOIN THE SUMMER TEST DRIVE! You are invited to test drive Trade Id..
3
07/13$ZGNX Aug $60 calls up to 1,455X last trade $5.20 after action started at $3...
1
More tweets
Qtime:163
News from SeekingAlpha
07/17IOMACHINE RUNTHROUGHS : Buy GW Pharma On Current Approval And Future Catalysts 
07/16BIOTECH ANALYSIS CENTRAL PHARMA NEWS : Zogenix's Late-Stage Win, Zynerba's Bounc.. 
07/15YOUR DAILY PHARMA SCOOP : Zogenix Zooms, Zynerba's Changing Fortunes, AbbVie Pro.. 
07/13Midday Gainers / Losers (07/13/2018) 
07/13Zogenix's Seizure Data Looks Good Enough To Put It Up Against A Major Competi.. 
Chart ZOGENIX, INC.
Duration : Period :
Zogenix, Inc. Technical Analysis Chart | ZGNX | US98978L2043 | 4-Traders
Technical analysis trends ZOGENIX, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 72,2 $
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Stephen J. Farr President, Chief Executive Officer & Director
Cam L. Garner Chairman
Michael Patrick Smith CFO, Secretary, Treasurer & Executive VP
Bradley S. Galer Chief Medical Officer & Executive Vice President
Roger L. Hawley Director
Sector and Competitors
1st jan.Capitalization (M$)
ZOGENIX, INC.45.82%2 062
GILEAD SCIENCES8.00%100 185
VERTEX PHARMACEUTICALS18.38%45 900
REGENERON PHARMACEUTICALS-2.35%38 962
CELLTRION, INC.--.--%32 245
IQVIA HOLDINGS INC13.49%22 746